查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032392

內視鏡逆行性胰造影（ERCP）市場報告：按產品、手術、最終用戶和地區分類（2026-2034 年）

Endoscopic Retrograde Cholangiopancreatography Market Report by Product, Procedure, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球內視鏡逆行性造影（ERCP）市場規模達18億美元。展望未來，IMARC Group預測，該市場從2026年到2034年將以5.36%的複合年成長率成長，到2034年達到29億美元。

內視鏡逆行性造影（ERCP）是一種用於診斷和治療肝臟、膽囊、膽管和胰臟異常的影像學技術。此技術結合了X光和一根細長、柔軟、輕巧的內視鏡管，內視鏡管可依序通過食道、口腔和胃。這有助於檢測膽管阻塞、膽結石、感染疾病、腫瘤、胰管滲漏。此外，與開放性手術相比，此檢查創傷較小，並能提供關於胰膽系統的更詳細、更準確的資訊。因此，全球對用於檢查吞嚥困難、腹瀉、體重減輕、胃灼熱和便血等疾病的內視鏡治療設備的需求日益成長。

內視鏡逆行性胰膽管造影（ERCP）市場趨勢：

全球人口成長以及各種慢性胃腸道疾病（包括巴瑞特氏食道症、膽道疾病、克隆氏症、克隆氏症、發炎性腸道疾病、消化性潰瘍和胃食道逆流症 (GERD)）的盛行率上升，是推動市場發展的關鍵積極因素。此外，胰臟和肝臟良性腫瘤（尤其是在老年族群中）發生率的增加，以及全球癌症發生率的上升，都在推動市場發展。因此，醫院和診斷中心的擴張增加了對影像技術的需求，從而促進了市場成長。此外，各國政府和醫療機構對先進內視鏡設備的投入增加以及內視鏡檢查的加強也支持了市場成長。此外，消費者對微創手術的偏好不斷變化，以期更快康復和減輕疼痛，以及對內視鏡逆行胰膽管造影術 (ERCP) 設備（例如括約肌切開器）的認知度提高，都為市場創造了有利前景。此外，醫療基礎設施的持續改善和醫療旅遊的顯著成長預計也將推動市場成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球內視鏡逆行性胰造影（ERCP）市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 內視鏡
  • 內視鏡治療設備
    • 主要部分
      • 括約肌切開術
      • 破碎設備
      • 支架
      • 其他
  • 視覺化系統
  • 能源設備
  • 其他

第7章 市場區隔：依治療方式分類

  • 膽道括約肌切開術
  • 膽道支架置入術
  • 膽道擴張
  • 胰管括約肌切開術
  • 胰管支架置入術
  • 胰管擴張

第8章 市場區隔：依最終用戶分類

  • 醫院和診所
  • 門診手術中心
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Boston Scientific Corporation
    • CONMED Corporation
    • Cook Group Incorporated
    • Fujifilm Holdings Corporation
    • Hobbs Medical Inc.
    • Johnson & Johnson
    • Medi-Globe GmbH
    • Medtronic plc
    • Olympus Corporation
    • Shaili Endoscopy
    • Steris Corporation
    • Telemed Systems Inc.
Product Code: SR112026A6442

The global endoscopic retrograde cholangiopancreatography market size reached USD 1.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.9 Billion by 2034, exhibiting a growth rate (CAGR) of 5.36% during 2026-2034.

Endoscopic retrograde cholangiopancreatography (ERCP) is an imaging technique that diagnoses and treats abnormalities in the liver, gallbladder, bile ducts, and pancreas. It combines X-rays and a long, flexible, lightweight endoscope tube that passes through the esophagus, mouth, and stomach. It helps detect blockages, stones, infections, and tumors in the bile duct and fluid leakage from the pancreatic duct. Besides this, it is a less invasive procedure than open surgery and provides more detailed and accurate information about the pancreaticobiliary system. As a result, the demand for endotherapy devices is increasing across the globe to investigate dysphagia, diarrhea, weight loss, heartburn, and stool blood.

ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET TRENDS:

The growing global population and the rising prevalence of various chronic gastrointestinal (GI) and incessant biliary medical disorders, including Barrett's disease, biliary, liver, Crohn's, inflammatory bowel, and peptic ulcer disease, and gastroesophageal reflux disorder (GERD), represent one of the key factors positively influencing the market. In addition, the increasing occurrence of benign pancreas and liver tumors, especially among the geriatric population, along with the growing occurrence of cancer across the globe, is driving the market. In line with this, the expansion of hospitals and diagnostic centers is increasing the need for imaging techniques propelling the market growth. Furthermore, rising investments by governments and healthcare organizations of various countries in advanced endoscopy devices and improve endoscopy research is strengthening the market growth. Apart from this, the shifting consumer preference toward minimally invasive surgeries for a speedy recovery and minimal pain and rising awareness about ERCP devices like sphincterotomes are offering a favorable market outlook. Moreover, continuous improvements in healthcare infrastructure and a considerable rise in medical tourism are expected to propel market growth.

KEY MARKET SEGMENTATION:

Breakup by Product:

  • Endoscope
  • Endotherapy Devices
    • Sphincterotomes
    • Lithotripter
    • Stents
    • Others
  • Visualization Systems
  • Energy Devices

Breakup by Procedure:

  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dilatation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting
  • Pancreatic Duct Dilatation

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Hobbs Medical Inc., Johnson & Johnson, Medi-Globe GmbH, Medtronic plc, Olympus Corporation, Shaili Endoscopy, Steris Corporation and Telemed Systems Inc.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Endoscopic Retrograde Cholangiopancreatography Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Endoscope
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Endotherapy Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Sphincterotomes
      • 6.2.2.2 Lithotripter
      • 6.2.2.3 Stents
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast
  • 6.3 Visualization Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Energy Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Procedure

  • 7.1 Biliary Sphincterotomy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biliary Stenting
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biliary Dilatation
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pancreatic Sphincterotomy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Pancreatic Duct Stenting
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Pancreatic Duct Dilatation
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boston Scientific Corporation
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 CONMED Corporation
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Cook Group Incorporated
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Fujifilm Holdings Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Hobbs Medical Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medi-Globe GmbH
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Olympus Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Shaili Endoscopy
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Steris Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Telemed Systems Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Endoscopic Retrograde Cholangiopancreatography Market: Major Drivers and Challenges
  • Figure 2: Global: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Procedure (in %), 2025
  • Figure 6: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: North America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: North America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: United States: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: United States: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Canada: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Canada: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: China: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: China: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Japan: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Japan: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: India: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: India: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: South Korea: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: South Korea: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Australia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Australia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Europe: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Europe: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Germany: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Germany: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: France: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: France: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Italy: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Italy: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Spain: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Spain: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Russia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Russia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Latin America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Latin America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Brazil: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Brazil: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Mexico: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Mexico: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Country (in %), 2025
  • Figure 84: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Global: Endoscopic Retrograde Cholangiopancreatography Industry: SWOT Analysis
  • Figure 86: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Value Chain Analysis
  • Figure 87: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Endoscopic Retrograde Cholangiopancreatography Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Procedure (in Million USD), 2026-2034
  • Table 4: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Endoscopic Retrograde Cholangiopancreatography Market: Competitive Structure
  • Table 7: Global: Endoscopic Retrograde Cholangiopancreatography Market: Key Players